Opentrons announced Compliance Ready Software (CRS) for its Flex liquid handling robot, designed to meet FDA 21 CFR Part 11 requirements for electronic records in regulated labs. The software adds authentication, role-based access controls, signed audit trails, and electronic record integrity to the benchtop platform. Once activated, CRS operates in an irreversible compliance-ready mode that routes all activity through audited pathways.

The move targets a persistent gap in pharmaceutical and biotech R&D. Labs operating under GLP, GCP, or discovery validation requirements have historically faced a choice: deploy expensive enterprise automation platforms they can validate, or use accessible benchtop systems that cannot be used in regulated workflows. Many regulated processes remain manual as a result. Opentrons claims CRS delivers audit-ready automation at one-fifth the total cost of ownership of traditional GxP liquid handlers.

CRS is designed for non-GMP regulated environments, including pharma and biotech discovery, preclinical work, and contract research organizations running non-GMP services. It maintains the existing Opentrons App workflow for protocol authorship and run management, storing records locally on each instrument rather than requiring cloud infrastructure. The software will be generally available in August 2026 and can be enabled on any Flex robot globally.

Opentrons has deployed over 10,000 systems, including installations at every Top 20 U.S. research university and 14 of the 15 largest global biopharma companies. The company is backed by SoftBank and Khosla Ventures and positions its platform as the "execution layer for autonomous science" with open APIs connecting AI models to physical lab operations.